Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:01 2024-05-06 pm EDT			5-day change	1st Jan Change
573.6 ^USD	+0.20%		-0.58%	+8.06%

May. 02	Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing	MT
May. 01	Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540	MT

Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.

April 24, 2024 at 06:03 am EDT

From January 1, 2024 to March 31, 2024, the company has repurchased 5,346,868 shares, representing 1.38% for $3,000 million. With this, the company has completed the repurchase of 5,346,868 shares, representing 1.38% for $3,000 million under the buyback announced on November 14, 2023.

Latest news about Thermo Fisher Scientific

Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing	May. 02	MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540	May. 01	MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing	Apr. 29	MT
HSBC Raises Thermo Fisher Scientific's Price Target to $670 From $660	Apr. 29	MT
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	Apr. 29	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	Apr. 29	CI
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating	Apr. 29	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	Apr. 25	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644	Apr. 25	MT
Bernstein Adjusts Thermo Fisher Scientific Price Target to $553 From $544	Apr. 25	MT
JPMorgan Adjusts Thermo Fisher Scientific Price Target to $650 From $600	Apr. 25	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $650 From $620, Keeps Overweight Rating	Apr. 25	MT
Stifel Adjusts Price Target on Thermo Fisher Scientific to $600 From $595	Apr. 25	MT
Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $640	Apr. 25	MT
Barclays Adjusts Price Target on Thermo Fisher Scientific to $615 From $590	Apr. 25	MT
RBC Adjusts Price Target on Thermo Fisher Scientific to $662 From $657	Apr. 25	MT
Wolfe Research Raises Thermo Fisher Scientific's Price Target to $625 From $615	Apr. 24	MT
Baird Trims Thermo Fisher Scientific's Price Target to $620 From $621	Apr. 24	MT
Top Midday Stories: Tesla, Boston Scientific Shares Jump Post-Earnings; Major Airline Stocks Down on New DOT Rules; B. Riley Finally Submits 10-K, Sends Stock Soaring	Apr. 24	MT
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	Apr. 24
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $615 From $610	Apr. 24	MT
Transcript : Thermo Fisher Scientific Inc., Q1 2024 Earnings Call, Apr 24, 2024	Apr. 24
Futures Mostly Rise in Premarket Ahead of More Corporate Earnings; Asia, Europe Up	Apr. 24	MT
Tech Strength Lifts Wall Street Pre-Bell; Asia Rallies, Europe Up	Apr. 24	MT

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-22 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

573.6 USD

Average target price

625.5 USD

Spread / Average Target

+9.05%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.06%	219B
DANAHER CORPORATION	+6.94%	183B
INTUITIVE SURGICAL, INC.	+13.54%	136B
SIEMENS HEALTHINEERS AG	-4.83%	63.07B
EDWARDS LIFESCIENCES CORPORATION	+11.59%	51.28B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.76%	52.55B
AGILENT TECHNOLOGIES, INC.	+1.14%	41.21B
GE HEALTHCARE TECHNOLOGIES INC.	+3.21%	36.43B
RESMED, INC.	+26.11%	31.87B
PHILIPS NV	+18.00%	24.2B

Other Advanced Medical Equipment & Technology